Showing 17,241 - 17,260 results of 103,202 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (we decrease)) ))', query time: 0.99s Refine Results
  1. 17241
  2. 17242
  3. 17243

    S1 Data - by Angga Yudaputra (16792924)

    Published 2023
    “…We proposed the category CR B1ab(iii,v), C2a(ii) as the new conservation status of <i>N</i>. …”
  4. 17244

    S2 Data - by Angga Yudaputra (16792924)

    Published 2023
    “…We proposed the category CR B1ab(iii,v), C2a(ii) as the new conservation status of <i>N</i>. …”
  5. 17245
  6. 17246
  7. 17247
  8. 17248
  9. 17249
  10. 17250
  11. 17251
  12. 17252
  13. 17253
  14. 17254
  15. 17255

    DataSheet_1_A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.docx by Jiawen Zhang (586977)

    Published 2021
    “…In vitro, carvedilol decreased TLR2 expression in RAW 264.7 cells, further reducing KLK5 secretion and LL-37 expression and ultimately inhibiting rosacea-like inflammatory reactions. …”
  16. 17256

    DataSheet_1_A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.docx by Jiawen Zhang (586977)

    Published 2022
    “…In vitro, carvedilol decreased TLR2 expression in RAW 264.7 cells, further reducing KLK5 secretion and LL-37 expression and ultimately inhibiting rosacea-like inflammatory reactions. …”
  17. 17257

    DataSheet_2_A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.docx by Jiawen Zhang (586977)

    Published 2022
    “…In vitro, carvedilol decreased TLR2 expression in RAW 264.7 cells, further reducing KLK5 secretion and LL-37 expression and ultimately inhibiting rosacea-like inflammatory reactions. …”
  18. 17258

    DataSheet_2_A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.docx by Jiawen Zhang (586977)

    Published 2021
    “…In vitro, carvedilol decreased TLR2 expression in RAW 264.7 cells, further reducing KLK5 secretion and LL-37 expression and ultimately inhibiting rosacea-like inflammatory reactions. …”
  19. 17259
  20. 17260

    Deviation from standard dose-response curve by bnMAbs in a U87 target cell assay. by Laura E. McCoy (386535)

    Published 2015
    “…The data points are colored according to which site the bnMAb targets: high-mannose patch (magenta), CD4bs (red), V2 apex (blue), and MPER (green). The dotted line denotes a slope of 0.5. …”